NanoEntek, Inc. (KOSDAQ:039860)

South Korea · Delayed Price · Currency is KRW

4,180.00

+30.00 (0.72%)

At close: Sep 18, 2026

Market Cap	158.19B +42.2%
Revenue (ttm)	44.19B +29.6%
Net Income	5.86B +231.3%
EPS	163.01 +195.6%
Shares Out	37.84M
PE Ratio	25.64
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	198,100
Open	4,190.00
Previous Close	4,150.00
Day's Range	4,165.00 - 4,260.00
52-Week Range	3,015.00 - 9,390.00
Beta	0.74
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About NanoEntek

NanoEntek, Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally. It provides FREND system, a fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, a residual white blood cell counters; ADAMII/fluorescence stem cell counter; fluorescence cell counters and cell analyzers; brightfield cell counters; somatic... [Read more]

Industry Laboratory Analytical Instruments

Founded 1987

Employees 141

Stock Exchange KOSDAQ

Ticker Symbol 039860

Full Company Profile

Financial Performance

In 2025, NanoEntek's revenue was 38.13 billion, an increase of 25.16% compared to the previous year's 30.46 billion. Earnings were 1.58 billion, a decrease of -55.93%.

Financial Statements